Heterocyclic compounds as inhibitors of Vanin-1 enzyme
US10308615B2 · kind B2 · utility
3Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 16, 2016 |
| Grant date | Jun 4, 2019 |
| Priority date | — |
| Expiry date | May 16, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds, pharmaceutically acceptable salts thereof, are disclosed wherein the compounds have the structure of as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.